Xiangliang Yang
- Pharmaceutical Science top 0.02%
- Advanced Drug Delivery Systems 37
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery 120
- Biomedical Engineering top 0.05%
- Nanoplatforms for cancer theranostics 158
- Molecular Medicine top 0.2%
- Materials Chemistry top 0.5%
- Advanced Nanomaterials in Catalysis 29
-
- Extracellular vesicles in disease 32
- RNA Interference and Gene Delivery 30
-
- Cancer, Hypoxia, and Metabolism 26
-
- Photodynamic Therapy Research Studies 25
- Co-authors
- Huibi XuHuabing ChenLu GanZifu LiJun HuTuying YongYanbing ZhaoChen Xiao
- Journals
- Journal of the American Chemical Society (1 paper)Chemical Society Reviews (3 papers)Advanced Materials (9 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiangliang Yang
498 papers receiving 25.0k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Pharmaceutical Science 3.4k
- Biomaterials 6.4k
- Biomedical Engineering 11.4k
- Molecular Medicine 971
- Materials Chemistry 6.5k
Countries citing papers authored by Xiangliang Yang
This map shows the geographic impact of Xiangliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangliang Yang more than expected).
Fields of papers citing papers by Xiangliang Yang
This network shows the impact of papers produced by Xiangliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangliang Yang. The network helps show where Xiangliang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangliang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 7 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 15 | |
| 11 | 2024 | 26 | |
| 12 | 2023 | 23 | |
| 13 | 2023 | 19 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 21 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 15 | |
| 18 | 2021 | 94 | |
| 19 | 2021 | 2 | |
| 20 | Involvement of TGF-β and ROS in G1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Under UVA Irradiation in a 3D Spheroid Model | 2020 | 1 |
About Xiangliang Yang
Xiangliang Yang is a scholar working on Biomaterials, Pharmaceutical Science and Biomedical Engineering, having authored 510 papers that have together received 25.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (158 papers), Nanoparticle-Based Drug Delivery (120 papers), Advanced Drug Delivery Systems (37 papers), Extracellular vesicles in disease (32 papers), RNA Interference and Gene Delivery (30 papers), Advanced Nanomaterials in Catalysis (29 papers), Cancer, Hypoxia, and Metabolism (26 papers) and Photodynamic Therapy Research Studies (25 papers). The work is most often cited by research in Pharmaceutical Science (3.4k citations), Biomaterials (6.4k citations) and Biomedical Engineering (11.4k citations). Xiangliang Yang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Huibi Xu, Huabing Chen, Lu Gan, Zifu Li, Jun Hu, Tuying Yong, Yanbing Zhao, Chen Xiao, Yongan Tang and Jiangling Wan. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.